Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis. (Q34702316)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Thomas Kurt Eigentler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Claus Garbe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Benjamin Weide

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Christine Faller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Petra Büttner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Annette Pflugfelder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jürgen Bauer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Andrea Forschner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Friedegund Meier

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

29 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

e63137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

29 February 2020

copyright license

start time

29 April 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Final version of 2009 AJCC melanoma staging and classification

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0063137

Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3639278

Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma

26 October 2018

1 reference

12 December 2020

Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1

1 reference

12 December 2020

Contemporary surgical treatment of advanced-stage melanoma

1 reference

12 December 2020

Prognostic parameters in recurrent malignant melanoma

1 reference

12 December 2020

Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma

1 reference

12 December 2020

Survival with regional and distant metastases from cutaneous malignant melanoma

1 reference

12 December 2020

Factors affecting survival following local, regional, or distant recurrence from localized melanoma

1 reference

12 December 2020

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

1 reference

12 December 2020

Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma

1 reference

12 December 2020

Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma

1 reference

12 December 2020

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0063137

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

23638183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23638183%20AND%20SRC:MED&resulttype=core&format=json